Most side effects are gastrointestinal, most appear during dose escalation, and most fade
The retatrutide + cagrilintide stack is the most aggressive metabolic peptide combination community sources currently describe a triple-agonist GLP-1/GIP/glucagon backbone (retatrutide) layered with a long-acting amylin analog (cagrilintide)
Increasing glutathione levels could help prevent free radical damage to cells (Exner 2000)
Symptoms include skin rash, itching, shortness of breath, and swelling of the face, lips, or tongue
Underlying Conditions: Seek medical advice if symptoms persist, worsen, or are accompanied by fever, rash, or headache